Pacira BioSciences, Inc. — Director's Dealing 2017

Dec 19, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pacira Pharmaceuticals, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2017-12-15

Reporting Person: Riker Lauren Bullaro (Vice President, Finance)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-12-15	Common Stock	S	340	$43.70	Disposed	10442	Direct

Footnotes

F1: Includes 719 shares of common stock acquired under the issuer's employee stock purchase plan in June 2017.